Gynecologic Cancers in China: Which Hospitals Should You Look At First?

“Gynecologic cancer” is not one disease. Cervical cancer, ovarian cancer, endometrial cancer, vulvar cancer, vaginal cancer, and gestational trophoblastic disease can need very different routes. A good first question is not “Which hospital is good for women’s cancer?” It is “Which exact cancer, which stage, and what decision needs to be made now?”

When China may be worth considering

• You need a second opinion on surgery, staging, fertility preservation, radiotherapy, chemotherapy, targeted therapy, immunotherapy, or recurrence management.
• You have ovarian cancer and want another view on primary surgery versus neoadjuvant chemotherapy, debulking surgery, PARP inhibitor planning, or genetic testing.
• You have cervical cancer and need treatment-sequence review, especially surgery versus chemoradiotherapy.
• You have endometrial cancer and need surgical staging, pathology review, molecular classification, or fertility-sparing discussion.

Where patients often get pushed onto the wrong path

• They see general gynecology when the case really needs gynecologic oncology.
• They accept surgery before pathology, imaging, and staging are clear.
• They do not ask about fertility preservation until after the treatment plan is already fixed.
• They ignore genetic testing, family risk, or maintenance therapy questions in ovarian cancer.
• They leave China without operation notes, pathology, discharge summary, chemotherapy plan, radiotherapy dose summary, or follow-up schedule.

Departments that matter

Gynecologic cancers may involve gynecologic oncology, medical oncology, radiation oncology, pathology, imaging, genetics, fertility preservation, urology, colorectal surgery, ICU, pain care, and rehabilitation. For ovarian cancer and advanced pelvic disease, surgery can be complex and may require cross-specialty planning.

Records to prepare

• Biopsy or surgical pathology, including tumor type, grade, stage if known, and margin or lymph node details if surgery happened.
• Pelvic MRI, CT, PET-CT, ultrasound, and DICOM files where possible.
• CA-125, HE4, CEA, CA19-9, SCC antigen, HPV results, or other markers if relevant.
• BRCA, HRD, MMR/MSI, POLE, p53, PD-L1, or other molecular results if already tested.
• Prior surgery, chemotherapy, radiotherapy, targeted therapy, immunotherapy, complications, and current symptoms.
• Fertility goals, menopause status, pregnancy status, and whether preserving uterus or ovaries is a real priority.

Hospitals to check first

Other names you may hear

Large women-and-children hospitals, top obstetrics and gynecology hospitals, and provincial cancer hospitals may also be relevant. The key distinction is whether the team is handling gynecologic oncology, not only general gynecology.

Questions to ask before you choose

• Which exact cancer is this: cervical, ovarian, endometrial, vulvar, vaginal, or another diagnosis?
• Is the first decision surgery, radiotherapy, chemotherapy, fertility preservation, pathology review, or recurrence management?
• Will the case be reviewed by gynecologic oncology rather than general gynecology?
• Do I need genetic or molecular testing before treatment is finalized?
• If radiotherapy or chemotherapy is proposed, can I complete it in China or continue safely at home?
• What written records will I receive before leaving China?

---

Use this as a shortlist, not a diagnosis. Hospitals change doctors, departments, appointment rules, international-patient services, and pricing routes. Before you travel, verify the exact department, doctor or team, documents needed, estimated timeline, cost route, and follow-up plan.

Medical disclaimer: This page is practical orientation, not medical advice, diagnosis, treatment advice, legal advice, or insurance advice.